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Magi 4, now renamed δ-hexatoxin-Mg1a, is a 
43-residue neurotoxic peptide from the venom of 
the hexathelid Japanese funnel-web spider 
(Macrothele gigas) with homology to 
δ-hexatoxins from Australian funnel-web 
spiders. It binds with high affinity to receptor 
site 3 on insect voltage-gated sodium (NaV) 
channels but, unlike δ-hexatoxins, does not 
compete for the related site 3 in rat brain despite 
being previously shown to be lethal by 
intracranial injection. To elucidate differences in 
NaV channel selectivity we have undertaken the 
first characterisation of a peptide toxin on a 
broad range of mammalian and insect NaV 
channel subtypes showing that 
δ-hexatoxin-Mg1a selectively slows channel 
inactivation of mammalian NaV1.1, NaV1.3, and 
NaV1.6 but more importantly shows higher 
affinity for insect NaV1 (para) channels. 
Consequently, δ-hexatoxin-Mg1a induces tonic 
repetitive ﬁring of nerve impulses in insect 
neurons accompanied by plateau potentials. In 
addition, we have chemically synthesised and 
folded δ-hexatoxin-Mg1a, ascertained the 
bonding pattern of the four disulfides and 
determined its three dimensional solution 
structure using NMR spectroscopy. Despite 
modest sequence homology, we show that key 
residues important for the activity of scorpion 
α-toxins and δ-hexatoxins are distributed in a 
topologically similar manner in 
δ-hexatoxin-Mg1a. However subtle differences 
in the toxin surfaces are important for the novel 
selectivity of δ-hexatoxin-Mg1a for certain 
mammalian and insect NaV channel subtypes. As 
such, δ-hexatoxin-Mg1a provides us with a 
specific tool with which to study channel 
structure and function and determinants for 
phyla- and tissue-speciﬁc activity. 
 
 
Voltage-gated sodium (NaV)4 channels are 
responsible for the generation and propagation of 
electrical signals in excitable cells. At least nine 
different genes encoding distinct NaV channels 
isoforms have been identified, and functionally 
expressed, in mammals (1). They are characterized 
by their sensitivity to TTX, with NaV1.5, NaV1.8 
and NaV1.9 being TTX-insensitive or TTX-resistant 
and the remaining subtypes being sensitive to 
nanomolar concentrations of TTX. In addition, 
localization of the subtypes also varies, with 
NaV1.1–1.3 mostly distributed in the central 
nervous system, NaV1.6–1.9 principally located in 
the peripheral nervous system, and NaV1.4 and 
NaV1.5 found in skeletal and cardiac muscle, 
respectively. The structural diversity of NaV 
channels also coincides with variations in 
physiological and pharmacological properties (2). 
In contrast, insects express only one gene (para) 
that undergoes extensive alternative splicing and 
RNA editing (3). The para-encoded NaV channel is 
exceptionally well conserved across diverse orders 
of insects, with the level of identity ranging from 
87 to 98% (3). This is one reason why insecticides 
that target insect NaV channels have broad activity 
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across many insect orders. In contrast, para-type 
NaV channels have significantly lower levels of 
identity with the various types of mammalian NaV 
channels with the level of identity typically around 
50–60% (3). This explains why a high degree of 
phylogenetic specificity can be achieved with both 
NaV channel toxins and insecticides that target the 
NaV channel. 
At least seven distinct toxin binding sites have 
been identified by radioligand binding and 
electrophysiological studies on vertebrate and 
insect NaV channels (4,5). Toxins interacting with 
these neurotoxin receptor site have been 
instrumental in the study of NaV channel topology, 
function, and pharmacology (6). In particular, a 
wide range of scorpion α-toxins, sea anemone 
toxins and spider δ-hexatoxins [formerly 
δ-atracotoxins, (7)] compete for binding to receptor 
site-3 on the extracellular surface of NaV channels. 
These polypeptide toxins all inhibit the fast 
inactivation of NaV channels to prolong Na+ 
currents (INa), despite huge diversity in primary and 
tertiary structures (8,9). Nevertheless, receptor 
site-3 has not yet been fully characterized but 
believed to involve domains DI/S5-S6, DIV/S5-S6 
as well as DIV/S3-S4 (for references see (9). Most 
importantly, however, toxin characterization is 
often limited to studies using whole cell INa or 
binding studies on neuronal membranes where 
there are mixed populations of NaV channel 
subtypes. For all of these toxins, the precise pattern 
of NaV channel subtype selectivity is either 
unknown, or at best incomplete. 
Recently, it was found that receptor site-3 was 
also recognized by a 43-residue spider toxin, 
originally named Magi 4, from the hexathelid 
spider Macrothele gigas (Iriomote, Japan). It binds 
with high affinity to insect NaV channels but, 
similar to scorpion α-like toxins, does not compete 
for the related site-3 in rat brain synaptosomes, 
despite being lethal by intracranial injection (10). 
Magi 4 shares significant homology to four 
δ-hexatoxin (HXTX)-1 family peptides and 
δ-actinopoditoxin-Mb1a (formerly 
δ-missulenatoxin-Mb1a; Fig. 1) but no sequence 
homology to scorpion α-toxins. Neurochemical 
studies have shown that δ-HXTX-1 toxins compete 
at nanomolar concentrations with both 
anti-mammalian (e.g. Aah2, Lqh2) and anti-insect 
(e.g. LqhαIT) scorpion toxins for site-3 (11-13). 
The three-dimensional structures of δ-HXTX-Ar1a 
and δ-HXTX-Hv1a peptides have been determined 
(14,15) and possess core β regions stabilized by 
four disulfide bonds, placing them in the inhibitory 
cystine knot (ICK) structural family (16). 
The aim of this study was to firstly determine 
the solution structure of Magi 4 and secondly to 
investigate the ability of Magi 4 to discriminate 
between different NaV channels subtypes. Here we 
report the tertiary structure of Magi 4 by 1H-NMR 
and show its disulfide bonding pattern and 3D 
structure is homologous to δ-HXTX-1 toxins. We 
highlight the key residues in Magi 4 appear to be 
topologically similar to those residues known to be 
part of the pharmacophore for site-3 scorpion 
α-toxins, despite Magi 4 having a different overall 
structure to scorpion α-toxins (11). In addition, we 
provide a detailed characterization of the selectivity 
and mode of action of Magi 4 on nine cloned 
mammalian and insect NaV channel subtypes, 
including a detailed characterization on insect 
neurotransmission. Given that the toxin potently 
slows the inactivation of NaV channels it should be 
renamed δ-hexatoxin-Mg1a (δ-HXTX-Mg1a) in 
accordance with the rational nomenclature recently 
proposed for naming spider peptide toxins (7) (see 
ArachnoServer spider toxin database; 
http://www.arachnoserver.org).  
 
EXPERIMENTAL PROCEDURES 
 
Peptide synthesis– δ-HXTX-Mg1a (43 residues) 
was chemically synthesized by native chemical 
ligation involving the coupling of a 
Cys(17)1–19-thioester peptide (N-terminal 19 
residues) and Cys20–43 peptide (C-terminal 24 
residues). The N-terminal Cys residue of the former 
peptide was protected by the Acm group to prevent 
cyclization and oligomerization. The solid-phase 
synthesis of the Cys(17)1–19-thioester and 
Cys20–43 peptides were performed using a ABI 
433A peptide synthesizer using the Boc strategy on 
a Boc-Asn(Xan)-S-CH2-CH2-CO-Leu-Pam resin 
(0.5 mmol) and Boc-Cys(4-MeBzl)-Merrifield resin 
(0.3 mmol), respectively. The peptide chains were 
elongated using in situ neutralization protocols of 
coupling with Boc-amino acid/HBTU/HOBt/DIEA 
(4/4/4/6 equiv.). After chain assembly was 
completed, the peptide resins obtained were treated 
with HF in the presence of p-cresol (to protect Trp 
residues) and 1,4-butanedithiol (as an oxygen 
scavenger) at –5 ºC for 1 h to remove all of the 
protecting and anchoring groups except the Acm 
group on the Cys1 residue. The crude products were 
then purified by preparative RP-HPLC using a 
YMC-Pak ODS column (30 x 250 mm) to obtain 
195 mg (16%) and 75 mg (8.4%) of purified 
peptides, respectively.  
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The N-terminal Cys(17)1-19-thioester and 
C-terminal Cys20-43 peptides were then allowed to 
ligate by solubilizing them in freshly degassed 0.1 
M sodium phosphate buffer (10 ml), pH 8.4, 
containing 6 M guanidium hydrochloride 
(Gdn·HCl). Thiophenol (0.40 ml) was then added, 
the whole mixture stirred for 24 h at room 
temperature and then treated with DTT (1.6 mmol). 
After 20 min the pH was acidified to less than 2 
using 1 M HCl. The mixture was washed with ether 
and Cys(17)1–43 peptide purified from the aqueous 
layers by preparative RP-HPLC using a linear 
gradient (20-40% CH3CN in 0.1% TFA for 80 min) 
to obtain 51 mg (41%) of purified peptide.  
To remove the Acm group, a 9.6 mM solution of 
Cys(17)1–43 (50 mg) was made up in 5 ml 95% 
TFA containing anisole (50 μl) and 0.77 mmol Ag 
trifluoroacetate was added and stirred for 2 h at 
room temperature. The product was precipitated as 
the Ag salt, by adding ether to the reaction mixture, 
and was dissolved in 0.1 M phosphate buffer, pH 
8.4, containing 6 M Gdn·HCl. DTT (3.8 mmol) was 
added to the solution and stirred for 0.5 h at room 
temperature. After the addition of 1 M HCl, the 
resulting AgCl was removed by filtration and the 
filtrate was applied to preparative RP-HPLC using 
a linear gradient (20-40% CH3CN in 0.1% TFA for 
80 min) to obtain 23 mg (46% yield) of the reduced 
peptide (8 SH-peptide (1-43)).  
The eight free cysteines were allowed to oxidize 
in air for 4 days at 4 °C in 0.1 M aqueous 
ammonium acetate (pH 7.6) containing 2 M 
Gdn·HCl, 0.1 mM GSSG and 1 mM GSH. The 
peptide:GSSG:GSH ratio was 1:10:100. The 
solution was then diluted 2-fold with cold water 
(4 °C) to a final peptide concentration of 5 μM. 
After 3 days at 4 ºC, the mixture was acidified to 
pH 2 by adding TFA and the folded peptide was 
desalted and purified by preparative RP-HPLC 
using a linear gradient (17-37% CH3CN in 0.1% 
TFA for 80 min) to obtain 5.3 mg from the previous 
23 mg (23% yield). 
ESI/Q-TOF Mass Spectrometry–All masses 
obtained during chemical synthesis were confirmed 
by electrospray ionization mass spectrometry using 
an ESI/Q-TOF mass spectrometer (Micromass, 
Manchester, U.K.). Peptides were mixed with 1% 
(v/v) formic acid / 70% (v/v) CH3CN and data 
analyzed using MassLynx v3.4 software 
(Micromass).  
Capillary Electrophoresis–Capillary zone 
electrophoresis (CZE) analyses were performed on 
a Jasco CE800 system (Jasco, Japan) equipped with 
a UV detector connected to a Shimadzu CR-4A 
recorder and a capillary (0.1 µm ID, 70 cm length, 
50 cm to detector). 20 mM sodium citrate buffer 
(pH 2.5) was used for the analyses. Samples 
dissolved in migration buffer were applied 
hydrodynamically to the capillary (height 20 cm, 
15 s) and analyses were performed with a 20 kV 
constant voltage drop and monitored at 210 nm. 
Circular Dichroism (CD) Measurements–CD 
spectra were obtained on a Jasco J-725 
spectropolarimeter (Jasco, Japan). The spectra were 
measured from 260 to 180 nm in 60% TFE, pH 7.1, 
at room temperature, with a 1 mm path-length cell. 
Data were collected at 0.1 nm with a scan rate of 
100 nm/min and a time constant of 1 s. The 
concentration of the toxins was 30 µM, as 
determined by amino acid analysis. Data from 10 
separate recordings were averaged and analyzed by 
the method of Bohm et al. (18). 
Iodination of LqhαIT and Binding Assays–The 
toxin was radio-iodinated with bovine milk 
lactoperoxidase (EC 1.11.1.7, Sigma-Aldrich, 
Germany) using 0.7 lactoperoxidase units, 1 nmole 
of toxin and 0.5 mCi carrier-free Na125I (Amersham, 
UK) (19). The displacement assays were performed 
as previously described (19) (see supplementary 
information). 
NMR Experiments–Synthetic δ-HXTX-Mg1a 
(4.7 mg) was dissolved to a final concentration of 
3.7 mM in 250 μl of H2O/D2O (90/10; v/v) 
containing 50 mM NaN3 in a susceptibility-matched 
microcell (Shigemi, Japan). The pH was adjusted to 
2.4. 
NMR spectra were recorded on a Bruker 
DMX-750 spectrometer. The temperature was set to 
298 K. Chemical shifts were referenced to internal 
TSP. 2D DQF-COSY, NOESY and TOCSY 
experiments were performed using standard pulse 
sequences and phase cycling. The NOESY spectra 
were acquired with mixing times of 50 ms and 200 
ms. The TOCSY spectrum was recorded with a spin 
lock time of 71 ms. The 2D spectra were recorded 
using time-proportional phase incrementation for 
quadrature detection in the F1 dimension. For water 
suppression, the NOESY experiments include the 
WATERGATE sequence, and the DQF-COSY and 
TOCSY experiments included selective low-power 
irradiation during the relaxation delay. The TOCSY 
and NOESY spectra were recorded with 512 (t1) x 
2K (t2). The DQF-COSY spectrum was recorded 
with 512 (t1) x 8K (t2) for an estimation of the 
coupling constants. The spectra were processed 
using the XWIN-NMR 2.5 program (Bruker 
Biospin) running on an O2 workstation (Silicon 
Graphics). Chemical shift assignments have been 
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deposited in the BioMagResBank (BMRB), 
accession code 11044. 
Structural Calculations–Proton signal 
assignments were achieved using the standard 
strategy described by Wüthrich with the graphical 
software ANSIG.3.3. The DQF-COSY and TOCSY 
spectra gave the spin system fingerprint of the 
peptide. The spin systems were then sequentially 
connected using the NOESY spectra. Interproton 
distance restraints were obtained from the NOESY 
spectra acquired with a mixing time of 200 ms. The 
NOE volumes were converted into four ranges of 
distance restraints classified as strong (1.8–2.7 Å), 
medium (1.8–3.3 Å), weak (1.8–5.0 Å), and very 
weak (1.8–6.0 Å). The backbone 3JNH-Hα coupling 
constants were estimated or directly measured from 
a 1D spectrum or the high-digital resolution 
DQF-COSY spectrum using the DECO program 
(Bruker Biospin). Hydrogen bonds were identified 
using amide-proton temperature coefficients from 
NOESY spectra obtained at 288 K, 298 K, 308 K, 
318 K and 328 K. 
The structural calculations were performed using 
the X-PLOR-NIH 2.9.1 program with 576 
NOE-based distance restraints, which contain 207 
intraresidue, 181 sequential, 60 medium-range and 
128 long-range restraints. In the first stage, the 
starting extended strand structure was subjected to 
10 ps and 1,000 steps of torsion-angle molecular 
dynamics at 50,000 K. The structures were then 
subjected to 15 ps and 1,500 steps of a 
slow-cooling torsion angle molecular dynamics 
stage in which the temperature was reduced from 
50,000 K to 298 K over 250 steps. Finally, the 
structures were subjected to 200 steps of 
conjugated-gradient minimization. The initial runs 
for structure calculations were performed without 
hydrogen bond and disulfide bond restraints and the 
obtained structure was examined.  
The structures were checked for violations of 
geometric and experimental restraints, and atom 
overlapping, using the AQUA3.2 and 
PROCHECK-NMR3.4 programs. Finally, a set of 
20 conformers was selected based on the lowest 
X-PLOR energy. Structures were analyzed and 
visualized with the MOLMOL 2k.1 program. 
Neuronal Isolation Procedures and NaV Channel 
Expression–Characterization of the actions of 
δ-HXTX-Mg1a on native INa were performed using 
acutely dissociated newborn rat DRG neurons and 
cockroach DUM neurons from the terminal 
abdominal ganglia of adult male American 
cockroaches (Periplaneta americana) as previously 
described (20,21). Following isolation, recordings 
were made within 24 hours. 
For expression in Xenopus laevis oocytes, the 
rNaV1.1, rNaV1.2, and mNaV1.6 genes were 
subcloned into pLCT1. The rNaV1.3, rNaV1.4, 
hNaV1.5, DmNaV1, and tipE genes were subcloned 
into vectors pNa3T, pUI-2, pcDNA3.1, 
pGH19-13-5 and pGH19 respectively. For in vitro 
transcription, these plasmids were linearized with 
NotI. The rNaV1.7/pBSTA.rPN1 and 
hβ1/pGEM-HE were linearized with SacII and NheI, 
respectively. Capped cRNAs were then synthesized 
from linearized plasmid using the T7 
mMESSAGE-mMACHINE transcription kit 
(Ambion). The rβ1/pSP64T and hNaV1.8/pBSTA 
vectors were linearized with EcoRI and NotI 
respectively, and transcribed with the SP6 
mMESSAGE-mMACHINE transcription kit 
(Ambion). 
Stage V-VI oocytes were harvested from the 
ovarian lobes of anaesthetized female X. laevis 
frogs as described previously (22). The oocytes 
were injected with up to 50 nl of cRNA at a 
concentration of 1 ng nl–1 using a Drummond 
microinjector (Ambion). The ND96 solution used 
for incubating the oocytes contained (in mM): NaCl 
96, KCl 2, CaCl2 1.8, MgCl2 2, HEPES-acid 5 (pH 
7.4), supplemented with 50 mg l–1 gentamycin 
sulfate. Whole-cell currents from oocytes were 
recorded 2–5 days after injection. 
Electrophysiological Studies–Voltage- or 
current-clamp recordings from single DRG and 
DUM neurons were made using the whole-cell 
patch-clamp technique of Hamill et al. (23). 
Recordings from X. laevis oocytes were performed 
using the two-electrode voltage-clamp method as 
described by Liman et al. (22).  
Experiments were performed at constant 
temperature 18–24 ˚C using either an AxoPatch 
200A patch-clamp amplifier or GeneClamp 500 
amplifier. Current and voltage pulse protocols were 
generated using the pClamp software system 
(Molecular Devices, Sunnyvale, CA, USA). Data 
were digitized at 10–25 kHz, and low-pass filtered 
at either 1 kHz (oocytes) or 5 kHz (DRG and DUM 
neurons) using a 4- or 5-pole Bessel filter (–3 dB). 
Leakage and capacitive currents were digitally 
subtracted with P-P/4 procedures and series 
resistance compensation set at >80% for all 
patch-clamped cells to minimize voltage errors. 
The extracellular Na+ concentration was reduced 
(see below) to minimise series resistance errors. 
The voltage-clamp data recorded in this study 
were rejected if there were large leak currents upon 
seal formation or currents showed signs of 
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inadequate space clamping. At the commencement 
of each experiment, oocytes or DUM neurons 
exhibiting leakage currents at a holding potential of 
-90 mV of more than –200 nA or –600 pA, 
respectively, were discarded. Only cells exhibiting 
stable leakage currents throughout the whole 
experiment (with a maximal deviation of  ± 10 % 
of initial value) were considered in the data 
analysis. To avoid overestimation of a potential 
toxin-induced shift in the current-voltage 
relationship as a result of inadequate voltage 
control when measuring large sodium currents in 
oocytes, only results from cells with currents lower 
than 1.5 µA were considered. Current-clamp data 
were rejected if the initial resting membrane 
potential was more depolarized than –45 mV. 
Recording Solutions–DRG neurons were 
perfused with an external solution containing (in 
mM): Na acetate 30, MgCl2 1, CaCl2 1.8, Cs acetate 
5, KCl 5, D-glucose 25, HEPES-acid 5, TEA-Br 
100, CdCl2 0.5, 4-AP 1 with the pH adjusted to 7.4 
with 1 M TEA-OH. Recordings were performed 
using micropipettes filled with a solution 
containing (in mM): CsF 135, Na acetate 8, 
HEPES-acid 5, with the pH adjusted to 7.0 with 
CsOH. The osmolarity of internal and external 
solutions was adjusted to 300–305 mOsmol litre–1 
with sucrose, prior to use, to reduce osmotic stress. 
Pipettes with resistances of 0.8–2 MΩ were used for 
recording INa from DRG neurons. 
For voltage-clamp experiments, DUM neurons 
were perfused with an external solution consisting 
of (in mM): NaCl 90, CsCl 5, CaCl2 1.8, 4-AP 5, 
TEA-Cl 50, verapamil 0.01, NiCl2 0.1, CdCl2 1, 
HEPES-acid 10, pH adjusted to 7.4 with HCl. 
Micropipettes were filled with an internal solution 
consisting of (in mM): CsF 135, MgCl2 1, NaCl 34, 
ATP-Na2 3, EGTA 5, HEPES-acid 10, pH adjusted 
to 7.35 with CsOH. For current clamp experiments, 
DUM neurons were perfused with an external 
solution consisting of (in mM): NaCl 190, KCl 3.1, 
CaCl2 5, MgCl2 4, HEPES-acid 10, with the pH 
adjusted to 7.4 with NaOH. Micropipettes were 
filled with an internal solution consisting of (in 
mM): K gluconate 160, KF 10, ATP-Mg 1, CaCl2 
0.5, NaCl 15, MgCl2 1, EGTA 10, HEPES-acid 10, 
with the pH adjusted to 7.4 with KOH. The 
osmolality of all solutions was adjusted to 400 
mOsm litre–1 with sucrose. Pipettes with resistances 
of 1.2–2 MΩ were used for recording currents from 
DUM neurons.  
Oocytes were perfused with ND96 solution. 
Voltage and current electrodes were filled with 3 M 
KCl and resistances were <1 MΩ. 
Voltage- and Current-clamp Recordings–In 
DRG neurons, the predominant TTX sensitivity of 
the Nav channels present in each cell was 
determined using a modified steady-state Nav 
channel inactivation (h∞) voltage-clamp protocol 
(24,25). This takes advantage of the separation of h
∞ curves for TTX-sensitive and TTX-resistant Nav 
channels (26). Only those found to have less than 
10% TTX-resistant INa were used for TTX-sensitive 
experiments. Of the remaining cells, those 
expressing sufficiently large TTX-resistant INa were 
used for experiments by perfusing with external 
solution containing 200 nM TTX.  
To determine the effect of the toxin on fast 
inactivation, currents were recorded in the absence, 
and presence, of a range of toxin concentrations. 
The action of the toxin on fast inactivation was 
assayed by measuring the late current remaining at 
50 ms (I50ms) for DRG and DUM neurons, or 30 ms 
for oocytes, as a fraction of peak current (Ipk). 
Currents were elicited by test potentials to –10 mV 
in DUM and DRG neurons or at depolarizing test 
potentials corresponding to maximal activation in 
oocytes (ranging from –10 to +10 mV). Test 
potentials were applied at 10 s (DRG and DUM) or 5 
s (oocytes) intervals. The normalised late current 
ratio (eg. I50ms / Ipk) gives the fractional probability 
for NaV channels not to be inactivated at the end of 
the test pulse. The concentration dependence for 
removal of inactivation was measured by plotting 
the normalised late current as a function of toxin 
concentration according to the following Hill 
equation (Eq. 1): 
 
 
 
 
where EC50 is the concentration at half maximal 
inhibition of fast inactivation, [toxin] is the toxin 
concentration and nH is the Hill coefficient. 
The effect of δ-HXTX-Mg1a on the 
voltage-dependence of Nav channel activation was 
determined using depolarizing test pulses from –90 
to +70 mV for 50 ms, in 5-mV (oocytes) or 10-mV 
(DRG and DUM) steps. The values for sodium 
conductance (gNa) were calculated according to the 
equation (Eq. 2): 
 
 
 
where INa is the absolute value of the sodium 
current at a given test potential (V) and Vrev is the 
reversal potential. The values of gNa and V–Vrev 
were then fitted to a Boltzmann equation (Eq. 3): 
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where gmax is maximal gNa, V1/2 is the half- maximal 
conductance, km is the slope factor. 
To determine the effect of δ-HXTX-Mg1a on the 
voltage-dependence of steady-state NaV channel fast 
inactivation (h∞) a two-pulse protocol with a 0.5-ms 
interpulse interval was applied. This consisted of a 
500 ms or 1 s conditioning prepulse (Vcond), in which 
the holding potential of –90 mV was stepped to 
potentials ranging from –130 up to +20 mV in 5-mV 
(oocytes) or 10-mV (DRG and DUM) increments, 
followed by a 50-ms test pulse (Vtest) to –10 mV in 
DRG or DUM neurons, or potentials corresponding 
to maximal activation in oocytes. Pulses were 
applied every 10 s. Data were normalised to the 
maximum peak control INa and fitted using a 
Boltzmann equation (Eq. 4): 
 
 
 
where V1/2 is the voltage at half-maximal 
inactivation, kh is the slope factor, V is the test 
voltage, and C is a constant or non-inactivating 
fraction (usually zero in controls). 
The effect of the toxin on the rate of recovery 
from NaV channel inactivation was examined by 
applying a standard two-pulse protocol with a 
variable interpulse interval (ΔT). A 50-ms 
conditioning prepulse (Vcond) was applied from a 
holding potential of –90 mV to –10 mV, followed 
by a 50-ms test pulse (Vtest), with an interpulse 
interval ranging between 0.5 ms and 4 s.  
Mathematical curve fitting was accomplished 
using GraphPad Prism version 5.00 for Macintosh 
(GraphPad Software, San Diego CA, USA). All 
curve-fitting routines were performed using 
non-linear regression analysis employing a least 
squares method. Comparisons of two sample means 
were made using a paired Student's t-test. Multiple 
comparisons were assessed by repeated measures 
ANOVA with a Bonferroni’s multiple comparison 
post-hoc test. A test was considered to be 
significant when P < 0.05. All data are presented as 
mean ± standard error of the mean (SEM) of n 
independent experiments. 
 
RESULTS 
 
Peptide Synthesis and 
Characterization–δ-HXTX-Mg1a was synthesized 
with its C-terminus as the free carboxyl, as 
observed for the native toxin by mass spectrometry 
and from the cDNA encoding gene (10). The 
structural identity between the synthetic and native 
toxins was verified by ESI/Q-TOF MS and CZE 
(supplemental Fig. S1 and Table S1). In a 
co-injection experiment, native δ-HXTX-Mg1a and 
synthetic δ-HXTX-Mg1a coeluted in a single sharp 
peak (supplemental Fig. S1A). Moreover, the CD 
spectra of synthetic and native δ-HXTX-Mg1a 
superimposed indicating that their secondary 
structures were similar. Both native and synthetic 
δ-HXTX-Mg1a were able to displace the binding of 
125I-LqhαIT from insect NaV channels in cockroach 
synaptosomes with similar IC50 values 
(supplemental Fig. S1B-C). 
NMR Spectroscopy–Sequence specific 1H 
resonance assignments for all residues observed 
were established using standard methods (27). NOE 
cross peaks were converted to distance restraints 
for structural calculation. From NMR experiments, 
582 distance constraints and 22 dihedral angle 
constraints were used for the structural calculations. 
The total of 582 distance restraints included 576 
NOE constraints and 6 hydrogen bonds (Fig. 1B). 
In addition, disulfide bond constraints were also 
used (Cys1-Cys15, Cys8-Cys20, Cys14-Cys31 and 
Cys16-Cys43). Simulated annealing calculations 
were started from an extended structure and 20 
structures were selected with the lowest XPLOR 
energy, which had no ≥ 0.4 Å NOE distance 
violations and no ≥ 5.0° angle violations from 100 
structures obtained at the final calculation (28). 
Structural statistics for these 20 converged 
structures are summarized in Table 1. Figure 2A 
shows a stereoview of the best-fit superposition of 
the backbone atoms (N, C, Cα and O) for 20 
converged structures. The root-mean-square 
deviations with respect to the mean coordinate 
positions are 0.483 Å for backbone atoms and 
1.178 Å for all heavy atoms of the disulfide-rich 
structured region (Gly2-Ala23 and Gln28-Glu32), 
excluding the non-structured loop (Trp24-Gln27) and 
C-terminal (Arg33-Cys43) regions. Analysis of the 
20 structures using PROCHECK-NMR and AQUA 
reveals that 95.1% of the backbone dihedral angles 
for the structured region lie in the most favored and 
additional allowed regions of the Ramachandran 
plot (29). 
Six protons from amide groups were identified 
to form hydrogen bonds according to the amide 
proton temperature coefficients (Supplemental Fig. 
S2). If the hydrogen bond was in agreement with 
amide temperature coefficients (> –4.6 ppb/K), and 
a hydrogen bond acceptor and an oxygen atom of 
the backbone was within 2.6 Å of the amide-proton, 
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the amide-proton was identified as a donor of the 
hydrogen bond. Hydrogen bond acceptors for all 
the protons were unambiguously determined from 
preliminary structure calculations. These restraints 
were then used in the following stage of structure 
calculations (1.8 ≤ d ≤ 2.12 Å for NHi-Oj and 2.7 ≤ 
d ≤ 3.2 Å for Ni-Oj) (30).  
Twenty-two dihedral angles estimated from the 
3JNH-Ha values were used as  angle constraints 
within the range of –90° and –40° for 3JNH-Hα < 5.5 
Hz (Ala6, Trp7, Cys15, Trp24, Cys31, Arg33, Lys36, 
Phe39), and between –160° and –80° for 3JNH-Hα > 8 
Hz (Ser3, Cys8, Lys9, Cys14, Tyr18, Asn19, Cys20, 
Ala23, Asn26, Gln28, Ser29, Glu32, Trp35, Glu42) 
following standard parameterization (31) (Fig. 1B). 
From the results of initial runs without using the 
disulfide bridge restraints, the disulfide patterns of 
Cys1-Cys15 and Cys16-Cys43 were unambiguously 
determined. Analyzing the distances between Sγi 
and Sγj of the remaining four cysteines, three types 
of disulfide patterns were possible (pattern I: 
Cys8-Cys14, Cys20-Cys31; pattern II: Cys8-Cys31, 
Cys14-Cys20; and pattern III: Cys8-Cys20, 
Cys14-Cys31). Three sets of structure calculations 
were performed with these possible restraints. The 
energy minimization was done in vacuo with the 
GROMOS96 43B1 parameters set, without reaction 
field (32), to determine the lowest energy state and 
thus the most stable disulfide pattern of 
δ-MSTX-Mg1a. Energy computations were done 
with the GROMOS96 (32) implementation of 
Swiss-PdbViewer (33). Total energy calculations 
for pattern I, II and III were –693.5, –892.7 and 
–1523.4 kJ/mol respectively, therefore 
unambiguously determining the remaining disulfide 
bridge patterns as Cys8-Cys20 and Cys14-Cys31. 
These disulfide bridges, along with Cys1-Cys15 
form an ICK motif (Fig. 2D), and a pattern (I-IV, 
II-VI, III-VII, V-VIII) identical to other δ-HXTX-1 
family members (14,15)Fig. 1A).  
Description of the three-dimensional structure– 
Figure 2A shows the best-fit superposition of the 
backbone atoms (N, Cα, and C) for the 20 
converged structures of δ-HXTX-Mg1a. The 
three-dimensional structure of δ-HXTX-Mg1a 
comprises several well-defined regions, consisting 
of an antiparallel β-sheet (strand 1: Asn19-Ala23, 
strand 2: Gln28-Glu32) with some secondary 
structural elements (Figs. 1B and 2B). We identified 
turns by the standard definition that the distance 
between Cαi and Cαi+3 is less than 7 Å (34,35). The 
two turns involve Ser3 to Ala6 (turn 1) and Cys15 to 
Tyr18 (turn 2). The average dihedral angles for 
residues at positions i+1 and i+2 are follows: 2 = 
–40°, φ2 = 122° for Lys4 and 3 = 57°, φ3 = 84° for 
Arg5, 2 = –45°, φ2 = 128° for Cys16 and 3 = 98°, φ3 
= –2° for Gly17. Turn 1 is classified as a 
miscellaneous type IV β-turn. There is no hydrogen 
bonding in this turn conformation. Arg5 in turn 1 
shows a positive φ3 value, since non-glycine 
residues at position i+2 are rare in type II β-turns 
and furthermore arginine shows low turn potential. 
Turn 2 is assigned as a typical type II β-turn (βγL). 
In this turn, the Cys15 oxygen atom forms hydrogen 
bonding with the Tyr18 amide-proton (Fig. 1B). The 
region Trp24 to Gln27 is not well defined by the 
NMR data.  
Electrophysiological Studies on Mammalian NaV 
Channels–The effects of δ-HXTX-Mg1a were 
initially examined on neonatal rat DRG neurons as 
these were employed in the original 
characterization of δ-HXTX-1 and δ-AOTX-Mb1a 
toxins (36-38). Rat DRG neurons express two types 
of NaV channel currents, TTX-sensitive (mainly 
NaV1.1, NaV1.6 and NaV1.7) and TTX-resistant 
(NaV1.8 and NaV1.9) (26,39). Like δ-HXTX-1 
toxins, δ-HXTX-Mg1a slowed inactivation of 
TTX-sensitive INa in DRG neurons (Fig. 3A). This 
was observed as a sustained current in the presence 
of the toxin during depolarizing test potentials to 
–10 mV in which INa are fully inactivated in the 
absence of toxin. This is most likely the result of a 
marked slowing of transitions between open and 
open-inactivated states. The maximum degree of 
slowing of inactivation after 50 ms was 26.3 ± 
4.4% (n = 7) of control peak INa at 300 nM, with an 
EC50 of 46 nM (Fig 3E). This steady-state current 
was completely blocked by 100 nM TTX indicating 
that it is mediated exclusively via NaV channels 
(data not shown). In parallel, the peak INa amplitude 
recorded at –10 mV transiently increased but after 5 
min perfusion was slightly reduced by 6.6 ± 11.0% 
(n = 7). 
Similar to δ-HXTX-1 toxins (37,38), this effect 
was accompanied by a modest 10 mV 
hyperpolarizing shift in the threshold, but not the 
midpoint (V1/2), of NaV channel activation (Fig. 3C). 
Furthermore, δ-HXTX-Mg1a, at concentrations up 
to 1 μM, failed to modulate TTX-resistant INa (Fig. 
3B and D). Unlike δ-HXTX-1 toxins, however, the 
effect to slow NaV channel inactivation in 
TTX-sensitive DRG neurons was almost 
completely reversible after washing with toxin-free 
solution with a τon of 84.9 ± 18.4 s and τoff of 81.5 ± 
9.2 s (n = 5).  
Given the potent action of δ-HXTX-Mg1a on 
DRG neurons, we then assayed the effect of the 
toxin on eight mammalian NaV channel clones 
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(NaV1.1/β1-NaV1.8/β1) by analyzing gNa/V 
relationships and steady-state inactivation. Effects 
of the toxin on NaV1.9 channels were not 
investigated as this channel subtype currently fails 
to express in standard heterologous systems (40). 
Addition of δ-HXTX-Mg1a (up to 5 µM) to the bath 
medium produced a marked slowing of INa 
inactivation with a rank order in magnitude of 
NaV1.6/β1 > NaV1.1/β1 > NaV1.3/β1. However with 
NaV1.2/β1 and NaV1.7/β1 there were only weak 
effects to slow INa inactivation (Fig. 4A left-hand 
panels and supplemental Table 2S). These effects 
were accompanied by ~20% increase in peak INa 
amplitude with NaV1.6/β1 and NaV1.1/β1 channels 
but less significant changes with the remaining 
channel clones (supplemental Table 2S).  
The above effects were accompanied by only 
weak hyperpolarizing shifts in the 
voltage-dependence of activation (gNa) to a 
maximum ΔV1/2 of –8.9 mV for NaV1.3/β1 channels 
(Fig. 4A right-hand panels). In contrast, the toxin 
failed to slow INa inactivation of NaV1.4/β1, 
NaV1.5/β1 or NaV1.8/β1 channels at concentrations 
up to 5 µM (Fig. 4B). This lack of activity on 
NaV1.8/β1 channels is consistent with the lack of 
effects on TTX-resistant INa in DRG neurons that 
express both NaV1.8 and NaV1.9. 
In the mammalian NaV channel clones, 
steady-state inactivation (h∞) in the absence of toxin 
was best described by a single Boltzmann function. 
δ-HXTX-Mg1a (5 µM) caused a strong –19.7 mV 
hyperpolarizing shift in the voltage at half-maximal 
inactivation (V1/2) of NaV1.3/β1, but only weak 
non-significant shifts in V1/2 in NaV1.1/β1, NaV1.2/β1, 
NaV1.6/β1 and NaV1.7/β1 channels of less than –4 
mV (Fig. 4A right-hand panels). Moreover, in the 
presence of δ-HXTX-Mg1a steady-state 
inactivation became incomplete, causing the 
appearance of a non-inactivating component at 
prepulse test potentials more depolarized than –40 
mV, an effect previously noted with δ-HXTX-1 
toxins (37,38). This non-inactivating component 
was up to 27 ± 10% (n = 5) of peak current in the 
case of the NaV1.1/β1 channel (determined from C 
in Eq. 4) with a rank order in magnitude of 
NaV1.6/β1 > NaV1.1/β1 > NaV 1.3/β1 >> NaV1.2/β1 > 
NaV1.7/β1 (Fig. 4A right-hand panels). This was 
sufficient to induce significant changes in the slope 
factor, kh, in all NaV channel clones except 
NaV1.2/β1. Although time-dependent shifts in h∞ 
have been demonstrated in patch-clamp 
configurations (41) these are unlikely to account for 
the observed changes given the magnitude of the 
shift in NaV1.3/β1 and the absence of a 
non-inactivating component in controls. 
Electrophysiological Studies on Insect NaV 
Channels–In contrast to the clear effects, but 
modest potency, of the toxin on mammalian NaV 
channel gating and kinetics, δ-HXTX-Mg1a 
showed high affinity for the Drosophila NaV 
channel clone DmNaV1/TipE. This was evident 
firstly by a concentration-dependent increase in 
control peak INa amplitude up to a maximum of 290 
± 37% at 1 µM (n = 5; Fig. 5C). This was most 
likely the result of the marked 
concentration-dependent slowing of fast 
inactivation (Fig. 5A and C) with an EC50 of 22.8 
nM (Fig. 5H). Importantly δ-HXTX-Mg1a 
completely removed fast inactivation at 
concentrations of 1 µM (Fig. 5C). This was 
accompanied by up to a 21.8 mV hyperpolarizing 
shift in DmNaV1/TipE channel activation at 1 µM (n 
= 3, Fig. 5D). At a concentration of 15 nM, 
δ-HXTX-Mg1a also caused steady-state 
DmNaV1/TipE channel inactivation to become 
incomplete at prepulse test potentials more 
depolarized than –50 mV (non-inactivating 
component C = 49.2 ± 0.3%, Fig. 5B). At higher 
concentrations, the toxin completely prevented 
channel inactivation (Fig. 5D). 
To further probe the mode of action and 
insect-selectivity of δ-HXTX-Mg1a we assayed the 
toxin on cockroach DUM neurons, previously 
employed in the characterisation of δ-HXTX-Hv1a 
(42). Like δ-HXTX-Hv1a, δ-HXTX-Mg1a 
produced a potent time- and 
concentration-dependent slowing of INa inactivation 
(Fig. 5E and H). Maximum slowing after 50 ms 
was 46.1 ± 4.5% (n = 10) of control peak INa at 300 
nM δ-HXTX-Mg1a (Fig. 5E). The EC50 for the 
slowing of inactivation in DUM neurons was 823 
pM, ca. 56-fold lower than in DRG neurons (Fig. 
5H). Hence, although this toxin is not 
insect-specific, it shows a marked selectivity for 
insect NaV channels. The toxin also caused 14.3 and 
13.5 mV hyperpolarizing shifts in the V1/2 of NaV 
channel activation and steady-state inactivation, 
respectively (Fig. 5F).  
In DUM neurons, the slowing of inactivation 
described above was accompanied initially by a 
slight increase in the peak INa. This effect would 
reach a maximum after ca. 70 s followed 
immediately by a decrease in peak and late INa 
amplitude (Fig. 5E). If depolarising test pulses were 
abolished for 2 min after reaching steady-state 
toxin effects (e.g. after 4–5 min perfusion), peak 
and late INa amplitude increased markedly (Fig. 5G, 
trace marked ‘120 s’). If depolarising test pulses 
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(Δt = 10 s) were then reapplied, peak and late INa 
amplitude would decline back to steady-state levels 
within ca. 1 min (Fig. 5G, trace marked ‘180 s’). 
This effect may result from a slowed rate of 
recovery from fast inactivation or a 
voltage-dependent dissociation of the toxin from 
the channel. To test these possibilities we firstly 
assessed the effect of δ-HXTX-Mg1a (30 nM) on 
the rate of recovery from inactivation. While the 
toxin markedly increased repriming kinetics at 
interpulse intervals less than 3 ms, presumably 
reflecting a more rapid transition from open to 
closed states, the major effect of the toxin was to 
prolong the rate of recovery from fast inactivation 
at interpulse intervals greater than 3 ms, reflecting a 
slowed transition between closed-inactivated and 
closed states (Fig. 6A). This action resulted in a 
use-dependent decrease in peak INa amplitude 
during repetitive stimulation at 30 Hz (Fig. 6B).  
To determine whether the effect of the toxin was 
dependent on the holding potential the amplitude of 
the toxin-modified INa measured at the end of the 
test pulse was compared to peak INa at 
hyperpolarized holding potentials. In comparison 
with currents recorded at –90 mV, the fraction of 
the sustained INa, measured at the end of the 50 ms 
depolarizing test pulse (I50ms), compared with the 
peak INa amplitude (Ipk) was not significantly 
increased except at −150 mV (P < 0.05, n = 7, Fig. 
6C). In addition, to test if depolarising pulses could 
cause dissociation of the toxin, post-pulses up to 
+200 mV were applied immediately following a 
test pulse to –10 mV from –90 mV every 2 s. At 
this stimulation frequency there was some initial 
rundown in peak and late INa amplitude but the 
depolarizing post-pulses failed to cause any 
significant decrease in fractional I50ms/Ipk compared 
to data recorded in the absence of the post-pulse (P 
> 0.05, n = 5; Fig. 6D) 
To investigate the effects of the toxin on 
membrane excitability, DUM neurons were held 
under current-clamp conditions and action 
potentials evoked by depolarizing current pulses. 
δ-HXTX-Mg1a (100 nM) initially produced a 
prolongation of the repolarizing phase of the action 
potential (Fig. 7A). The falling phase of the action 
potential developed a broad shoulder in the last 
two-thirds of the repolarization phase (Fig. 7A). 
This caused a suppression of the 
afterhyperpolarization and an increase in spike 
duration resulting in ‘plateau’ action potentials (Fig. 
7A-C). Although a small depolarization of 3.1 ± 0.6 
mV (n = 5) was observed, neither resting 
membrane potential (RMP) nor spike amplitude 
were signiﬁcantly altered. Applying artiﬁcial 
hyperpolarization to a level 20–40 mV more 
negative than the RMP facilitated the appearance of 
these plateau potentials. In addition, the duration of 
plateau potentials were heavily influenced by the 
stimulation frequency such that the duration 
increased from ca. 70 ms at a RMP of –60 and 
stimulus interval of 10 s (Fig 7A) to ca. 300 ms at 
stimulus intervals of 1 min at a RMP held at –90 
mV (Fig. 7C). Interestingly, 100 nM δ-HXTX-Mg1a 
co-applied with 500 µM 3-4 diaminopyridine 
(3,4-DAP), a KV channel blocker, markedly 
prolonged the action potential duration to ca. 150 
ms at –60 mV (Fig. 7D) and ca. 800 ms at –90 mV 
(Fig. 7E). In this case, the action potential duration 
was more than 80-fold longer than with 3,4-DAP 
applied alone.  
As previously described DUM neurons are 
spontaneously active (43). At resting membrane 
potentials, most DUM neurones were capable of 
generating repetitive action potentials with firing 
frequencies of 31 ± 4.6 Hz (n = 4; Fig. 7F). In the 
presence of 100 nM δ-HXTX-Mg1a, repetitive 
plateau action potentials of ca. 70 ms duration 
would also occur spontaneously, albeit with a much 
reduced firing frequency of 3.2 ± 0.6 Hz (n = 4; Fig. 
7G). However, when the membrane potential was 
hyperpolarized to –80 mV, spontaneous plateau 
action potential duration increased up to ca. 500 ms 
but firing frequency was still low at 0.7 ± 0.2 Hz (n 
= 4; Fig. 7H). Using a ramp current from –80 mV 
at 0.2–0.4 nA/s there was also a –26 ± 2.0 mV shift 
in the threshold of spontaneous firing from –44.6 ± 
4.0 mV in controls to –70.6 ± 3.5 mV (n = 7) in the 
presence of 100 nM δ-HXTX-Mg1a. 
 
DISCUSSION 
Actions on NaV channel gating 
In all cases, δ-HXTX-Mg1a modulated channel 
gating and kinetics in a similar fashion to other 
δ-HXTX-1 toxins by causing: (i) a slowing/removal 
of NaV channel inactivation typically associated 
with an increase in peak NaV channel currents, (ii) a 
hyperpolarizing shift in the voltage dependence of 
channel activation, and (iii) a hyperpolarizing shift 
in the voltage dependence of steady-state 
inactivation. In insect neurons, further 
characterization revealed that the toxin (iv) slowed 
NaV channel repriming kinetics, and (v) caused a 
use-dependent reduction in INa amplitude. 
The toxin-induced increase in peak INa seen with 
DmNaV1 and to a lesser extent in DUM neurons, 
rNaV1.1, rNaV1.3 and NaV1.6, was in general well 
correlated with the magnitude of the sustained 
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current at the end of the depolarizing test pulse. 
This increase in peak INa can be explained by a 
delay in NaV channel fast inactivation from open to 
open-inactivated states. In contrast, δ-HXTX-Mg1a 
did not slow INa inactivation as markedly in NaV1.2, 
or NaV1.7 and therefore did not appreciably 
increase peak INa amplitude. This slowing of the 
transition from open to open-inactivated states also 
generated a non-inactivating component in the 
steady-state inactivation curve. This occurred at 
prepulse test potentials more depolarized than –40 
mV, an effect previously noted with δ-HXTX-1 
toxins (37,38). This is the result of a more rapid 
rate of recovery from fast inactivation when test 
pulses are separated by less than 3 ms. This reflects 
a higher proportion of transitions between open and 
closed states than open-inactivated to closed states 
via a closed-inactivated intermediate. 
The present study demonstrates that 
δ-HXTX-Mg1a displays differential NaV channel 
subtype specificity for NaV1.1/β1, NaV1.3/β1, and 
NaV1.6/β1 channels. This is consistent with its 
action on TTX-sensitive INa in rat DRG neurons 
that express mainly NaV1.1, NaV1.3 and NaV1.7 
channels (39). Importantly, however, 
δ-HXTX-Mg1a showed considerably higher 
affinity for invertebrate Drosophila DmNaV1 and 
cockroach NaV channels. Differences in the EC50 of 
δ-HXTX-Mg1a for dipterans (DmNaV1) vs. 
orthopterans (DUM neurons) have been previously 
noted for Lqh3 and δ-HXTX-Hv1a with cockroach 
vs. locust NaV channels (11,44). 
In cockroach DUM neurons, the slowing of NaV 
channel inactivation by δ-HXTX-Mg1a induced the 
development of prolonged plateau action potentials. 
This was accompanied by spontaneous repetitive 
ﬁring as a result of a hyperpolarizing shift in the 
threshold of action potential generation due to a 
negative shift in the voltage-dependence of NaV 
channel activation. The reduction in firing 
frequency observed in tonically active neurons 
probably reflects the reduced rate of recovery from 
fast inactivation at interpulse intervals greater than 
3 ms, presumably resulting from a slowing of the 
frequency of transition between the 
closed-inactivated and closed states. This is 
supported by the use-dependent decrease in INa 
amplitude during repetitive pulses. Interestingly, in 
DUM neurons, δ-HXTX-Mg1a produced greater 
inhibition of INa inactivation (Fig. 7I), with 
resultant prolongation of action potential duration, 
when the membrane potential was held at more 
hyperpolarized potentials (Fig. 8H). This suggests 
that the toxin partially dissociates from the channel 
at more depolarized potentials. Voltage-dependent 
dissociation of bound toxins from vertebrate NaV 
channels has already been demonstrated with 
scorpion and sea anemone toxins (9,11,45,46) and 
has also been observed with δ-HXTX-Hv1a on 
insect DUM neurons (42). However there was no 
indication of any depolarization-dependent 
dissociation of toxin from DUM neurons using 
hyperpolarized holding potentials or depolarizing 
post-pulse protocols.  
Comparison with orthologous δ-HXTX-1 toxins 
These actions on TTX-sensitive NaV channel 
subtypes in rat DRG and insect DUM neurons 
resemble the effects of other spider δ-HXTX-1 
toxins, with which δ-HXTX-Mg1a shares some 
sequence homology (37,38,42). In contrast to 
δ-HXTX-1 toxins, however, δ-HXTX-Mg1a is 
more efficacious on insect rather than mammalian 
NaV channel subtypes, including markedly different 
actions on repriming kinetics and use-dependent 
activity (this study and (10). δ-HXTX-Mg1a 
therefore shows greater similarity in its 
phyla-selective actions with scorpion α-like toxins. 
Like δ-HXTX-Mg1a, α-like toxins are toxic by 
direct injection into rat brain but fail to compete for 
site-3 on rat brain synaptosomes (9). Rat brain 
synaptosomal membranes are rich in mainly 
rNaV1.2/1.2a (78%) and rNaV1.1 (15%) (47). 
Consistent with a lack on inhibition of 125I-Lqh2 
binding to site-3 in rat brain synaptosomes, 
δ-HXTX-Mg1a showed only weak effects on 
NaV1.2/β1 at 5 µM. In addition, the toxin had even 
weaker activity on NaV1.7/β1 and no activity on 
NaV1.4/β1, NaV1.5/β1 and NaV1.8/β1 channels (Fig. 
4A). Although there is currently no reliable 
expression system for NaV1.9 channels, the lack of 
effect of δ-HXTX-Mg1a on TTX-resistant INa in 
DRG neurons would indicate that δ-HXTX-Mg1a 
does not have any appreciable affinity for this 
channel subtype. 
Scorpion α-like toxins, similar to 
δ-HXTX-Mg1a, specifically target NaV1.1, NaV1.3 
and NaV1.6 channels (48). Indeed the lethal actions 
of δ-HXTX-Mg1a, when injected intracranially, 
most likely results from its action on these channels 
and not NaV1.2. However, in the present study 
δ-HXTX-Mg1a was not active on NaV1.4/β1 which 
α-like, α-insect and anti-mammalian α-toxins, 
specifically target (49). Moreover, it was only 
weakly active on NaV1.7/β1 which the novel 
scorpion toxin OD1 specifically targets (50). 
δ-HXTX-Mg1a is therefore unique from scorpion 
α-toxins in that it does not target NaV1.2, NaV1.4 or 
NaV1.7 channels with high affinity. 
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Inhibitory cystine knot structural motif 
δ-HXTX-Mg1a shows sequence homology with 
δ-HXTX-1 family peptides and δ-MSTX-Mb1a 
(Fig. 1A). Indeed, the disulfide bonding 
arrangement of δ-HXTX-Mg1a was determined 
from the NMR data and found to be Cys(I-IV), 
Cys(II-VI), Cys(III-VII) and Cys(V-VIII), the same 
as δ-HXTX-Hv1a and δ-HXTX-Ar1a (14,15). Like 
δ-HXTX-1 family peptides, δ-HXTX-Mg1a also 
conforms to an ICK motif (8). The ICK motif 
consists of double- or triple-stranded antiparallel 
β-sheets connected by three disulfide bonds, which 
forms a small stable globular domain and has been 
observed in a variety of scorpion, spider, cone snail 
and snake toxins (16). Specifically, δ-HXTX-Mg1a 
comprises a double-stranded antiparallel β-sheet 
and a core region (Gly2-Ala23, Gln28-Glu32) (Fig. 
2B). The unstructured C-terminus (Arg33-Cys43) is 
most likely the result of a lack of medium- and 
long-range NOE constraints (Fig. 2A). 
Structure-function relationships 
Given that δ-HXTX-Mg1a has a similar solution 
structure to δ-HXTX-1 toxins (Fig. 2C) and 
comparable actions on NaV channel gating and 
kinetics, we posited that δ-HXTX-Mg1a might also 
share key residues important for binding to their 
NaV channel target. Figure 8(A-C) shows a 
comparison of residues that are conserved in spider 
δ-toxins targeting site-3 (14,15). A number of 
residues of these spider toxins are oriented in a 
similar fashion due to the sequence and structural 
homology between δ-HXTX-Mg1a and δ-HXTX-1 
toxins (Figs. 1A and 2C). A cluster of positively 
charged residues of δ-HXTX-Mg1a (Lys4, Arg5 and 
Arg33) appears in a similar position on the surface 
of δ-HXTX-Hv1a and δ-HXTX-Ar1a (Lys3, Lys4 
and Arg5). The positively charged Lys9 of 
δ-HXTX-Mg1a also seems to be oriented similarly 
to Lys10 of δ-HXTX-Hv1a and δ-HXTX-Ar1a, 
while aromatic residues Trp7 and Tyr22 are 
conserved in all these spider toxins. Finally, 
δ-HXTX-Mg1a possesses Ser6 in the same position 
as the nonpolar Asn6 of the δ-HXTX-1 toxins. 
However, other variations in the sequence of 
δ-HXTX-Mg1a are most likely responsible for the 
dramatic loss in affinity for rNaV1.2 observed in 
125I-Lqh2 binding experiments (10), and the present 
voltage-clamp experiments (Fig. 4A). In particular, 
the addition/removal of charged-side chains at 
positions 3, 10-12, 19, 34, 36, 40-43 are 
dramatically different to the corresponding residues 
in δ-HXTX-1 toxins. 
Site-3 toxins are proposed to slow the fast 
inactivation of Nav channels by preventing the 
outward movement of the S4 segments (6). 
δ-HXTX-Mg1a has been previously shown to 
compete with the scorpion α-insect toxin LqhαIT at 
subpicomolar concentrations for binding to insect 
site-3 (10). Recently, extensive mutagenesis studies 
have identified the pharmacophore of LqhαIT (51). 
Figure 8E shows the critical residues in LqhαIT 
form a functional surface composed of two 
domains; the NC-domain and core-domain. The 
positively charged residues of Lys4, Arg5, and Arg33 
in δ-HXTX-Mg1a, are oriented similarly to Lys8, 
Arg58, and Lys62 in the NC-domain of LqhαIT. The 
aromatic Trp7 and Tyr22 and basic Lys9 residues of 
δ-HXTX-Mg1a occupy similar positions to Phe17, 
Trp38, and Arg18 in the core-domain of LqhαIT. 
These aromatic residues in δ-HXTX-Mg1a are also 
present in δ-HXTX-1 toxins. Despite these 
topologically similar residues, δ-HXTX-Mg1a and 
δ-HXTX-1 toxins are smaller in bulk than scorpion 
α-toxins and lack aliphatic residues corresponding 
to the bioactive Ile57 and Val59 residues of LqhαIT. 
Indeed, δ-HXTX-Mg1a shows the greatest 
similarity in phyla-selectivity to scorpion α-like 
toxins eg Lqh3. Results from a mutagenesis study 
suggest that the core-domain of Lqh3 plays an 
important role in interaction with the receptor site 
and its toxin selectivity (52). Aromatic (Phe17, 
Phe39), positively charged (His15), and aliphatic 
residues (Pro18 and Leu45) were assigned to the 
bioactive surface in Lqh3. Importantly, the aliphatic 
Val21 and Ala23 of δ-HXTX-Mg1a are oriented 
similarly to those of Lqh3. The core-domain of 
δ-HXTX-Mg1a therefore seems to be involved in 
hydrophobic-aromatic interactions and play a role 
in its phyla-selectivity, although this awaits 
experimental confirmation. 
In conclusion, while peptide neurotoxins binding 
with site 3 on NaV channels are known to possess 
phyla-selectivity, our present study highlights a 
novel feature of δ-HXTX-Mg1a, namely 
target-selectivity for distinct NaV channel subtypes. 
This discriminating activity of the spider toxin is 
somewhat unexpected given that, like homologous 
δ-HXTX-1 toxins, it interacts with both 
mammalian and insect NaV channels. The effects of 
δ-HXTX-Mg1a on DmNaV1/TipE, NaV1.1/β1, 
NaV1.3/β1, and NaV1.6/β1 channels as opposed to 
the limited or lack of activity on NaV1.2/β1, 
NaV1.4/β1, NaV1.5/β1, NaV1.7/β1, NaV1.8/β1, and 
NaV1.9/β1 channels is remarkable because it 
represents the ﬁrst exhaustive characterisation of a 
selective interaction of any peptide neurotoxin 
across the complete range of NaV channel subtypes. 
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Our findings indicate that specific insect and 
mammalian NaV channel subtypes can be 
pharmacologically discriminated by their 
sensitivity to δ-HXTX-Mg1a as has only been 
partially described for scorpion α-toxins, sea 
anemone and other spider toxins (53,54). This 
should provide new tools to study the functional 
role and distribution of various NaV channel 
subtypes. Despite very low sequence homology 
with all three scorpion α-toxin groups (e.q. Lqh3, 
LqhαIT and Aah2), the three-dimensional structure 
of δ-HXTX-Mg1a reveals an apparently similar 
functional surface with a number of these site-3 
toxins and spider δ-toxins. Several positively 
charged and aromatic residues of δ-HXTX-Mg1a 
are arranged in a topologically similar manner to 
those of site-3 toxins. Thus, the structure of 
δ-HXTX-Mg1a provides an important lead for 
understanding phyla- and subtype-specificity and 
awaits the determination of the pharmacophore of 
the toxin.  
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FOOTNOTES 
 
The atomic coordinates and structure factors (code 2ROO) have been deposited in the Protein Data Bank, 
Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ 
(http://www.rcsb.org/). 
 
1 These authors contributed equally to this work. 
 
2 To whom correspondence should be addressed. Tel.: 61-2-9514-2230; Fax: 61-2-9514-8206; E-mail: 
Graham.Nicholson@uts.edu.au 
 
3 To whom correspondence should be addressed. Tel.: 52-777-329-1600; Fax: 52-777-317-2388; 
E-mail: corzo@ibt.unam.mx 
 
4 The abbreviations used are: HXTX, hexatoxin; Acm, acetamidomethyl; 4-AP, 4-aminopyridine; 
3,4-DAP, 3,4-di-aminopyridine; Boc, tert. butoxycarbonyl; BrZ, 2-bromobenzyloxycarbonyl; Bzl, benzyl; 
Xan, xanthenyl; CD, circular dichroism; CZE, capillary zone electrophoresis; DIEA, 
N,N-diisopropylethylamine; DRG, dorsal root ganglia; DUM, dorsal unpaired medial; DQF-COSY, 
double-quantum-filtered correlation spectroscopy; DTT, dithiothreitol; ESI/Q-TOF MS, electrospray 
ionization / quadrupole time-of-flight mass spectrometry; Gdn·HCl, guanidium hydrochloride; GSH, 
glutathione; GSSG glutathiol; HBTU, 2-{1H-benzotriazole-1-yl}-1,1,3,3-tetramethyluronium 
hexafluorophosphate; HEPES-acid, N-2-{hydroxyethyl}piperazine-N’-{2-ethanesulfonic acid}; HOBt, 
N-hydroxybenzotriazole; ICK, inhibitory cystine knot; KV channel, voltage-gated K+ channel; MeBzl, 
methylbenzyl; MSTX, missulenatoxin; NaV channel, voltage-gated Na+ channel; NOE, nuclear 
Overhauser effect; NOESY, NOE spectroscopy; RMP, resting membrane potential; RP-HPLC, 
reversed-phase high pressure liquid chromatography; TEA, tetraethylammonium; TFA trifluoroacetic 
acid; TFE, trifluoroethanol; TOCSY, total correlation spectroscopy; TSP, 3-(trimethylsilyl)[2,2,3,3-2H4] 
propionate; TTX, tetrodotoxin. 
 
 
FIGURE LEGENDS 
 
FIGURE 1. Primary and secondary structure of δ-HXTX-Mg1a. A, Comparison of the primary 
sequence of δ-HXTX-Mg1a and δ-HXTX-Mg1b (formerly Magi 14) with currently known members of the 
δ-HXTX-1 family and δ-AOTX-Mb1a (δ-actinopoditoxin-Mb1a, formerly δ-missulenatoxin-Mb1a). 
Homologies are shown relative to δ-HXTX-Mg1a; identities are boxed in gray while conservative 
substitutions are in gray italic text. Gaps (dashes) have been inserted to maximize alignment. The disulfide 
bonding pattern for the strictly conserved cysteine residues determined for δ-HXTX-Mg1a (this study), 
δ-HXTX-Ar1a (55) and δ-HXTX-Hv1a (15) is indicated above the sequences; it is assumed that 
δ-AOTX-Mb1a (36), δ-HXTX-Hs20.1a (8), and δ-HXTX-Hv1b (56) have the same disulfide bonding 
pattern. The percentage identity and homology with δ-HXTX-Mg1a is shown to the right of the sequences. 
B, Summary of δ-HXTX-Mg1a NMR data. Sequential NOEs, classified as very weak, weak, medium and 
strong, are represented by the thickness of bars. Filled diamonds indicate backbone amide protons that 
form hydrogen bonds. 3JNHCα coupling constants are indicated by ↑ (> 8 Hz) and ↓ (< 5.5 Hz). Secondary 
structure is shown at the bottom of the figure where rectangles represent β-turns (the type of turn is 
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indicated in the rectangle) and arrows represent β-sheets.  
 
FIGURE 2. Solution structure of δ-HXTX-Mg1a. A, Stereo view of the 20 lowest energy structures of 
δ-HXTX-Mg1a superimposed over the backbone atoms for the central core (Gly2-Ala23 and Gln28-Glu32). 
B, Stereo ribbon representation of the backbone of δ-HXTX-Mg1a showing the location of β-sheets (cyan 
arrows) and disulfide bonds (red tubes). C, Backbone overlay of δ-HXTX-Mg1a (green), δ-HXTX-Hv1a 
(blue, PDB code 1VTX) and δ-HXTX-Ar1a (cyan, 1QDP). The N- and C-termini are labeled. D, Stereo 
view of the inhibitory cystine knot (ICK) motif of δ-HXTX-Mg1a. The Cys14-Cys31 disulfide pierces a 
loop formed by the Cys1-Cys15 and Cys8-Cys20 disulfides (red) and the intervening sections of the 
polypeptide backbone (green) to create a pseudo-knot. Toxin models were prepared using the program 
MOLMOL (57). 
 
FIGURE 3. Differential effects of δ-HXTX-Mg1a on TTX-sensitive and TTX-resistant INa in rat DRG 
neurons. A-B, Superimposed current traces showing typical effects of a 5 min perfusion with 
δ-HXTX-Mg1a on TTX-sensitive (A) and TTX-resistant (B) INa elicited by a 50-ms test pulse from –90 
mV to –10 mV every 10 s. TTX-resistant INa were recorded in the presence of 200 nM TTX. C, Effects of 
300 nM δ-HXTX-Mg1a on normalized TTX-sensitive gNa/V relationships (n = 3–5). D, Lack of effect of 1 
μM δ-HXTX-Mg1a on normalized TTX-resistant gNa/V relationships. In both C and D, curves were fitted 
using Eq. 1 in the Materials and methods. E, Concentration-response curve of the amplitude of the late 
TTX-sensitive INa remaining at 50 ms as a fraction of peak control INa amplitude (n = 3–7). F, Timecourse 
of slowing of TTX-sensitive INa inactivation by δ-HXTX-Mg1a. Data shows the INa remaining at the end 
of the 50 ms test pulse as a fraction of peak INa amplitude during perfusion with 300 nM δ-HXTX-Mg1a 
(open circles), washout with toxin-free external solution (closed circles), and 200 nM TTX (grey circles). 
The τon and τoff values for δ-HXTX-Mg1a were determined by fitting single exponential equations to the 
data points.  
 
FIGURE 4. Differential effects of δ-HXTX-Mg1a on mammalian NaV channels expressed in Xenopus 
oocytes. A, Left-hand panels show superimposed current traces illustrating typical effects on mammalian 
NaV1.1–NaV1.3/β1 and NaV1.6–1.7/β1 following a 5 min perfusion with 5 μM δ-HXTX-Mg1a. Currents 
were elicited every 5 s by 100 ms test pulses from –90 mV to the voltage of maximum activation of the 
NaV channel subtype under control conditions. Corresponding right-hand panels show normalized gNa/V 
(squares) and h∞/V (circles) relationships in the presence (open symbols), and absence (closed symbols), 
of 5 μM δ-HXTX-Mg1a (n = 3–6). The gNa/V curves were fitted using Eq. 1 in the Materials and methods 
while h∞/V curves were fitted according to Eq. 4. B, Superimposed current traces showing typical lack of 
effect on mammalian NaV1.4/β1, NaV1.5/β1 or NaV1.8/β1 channel currents following a 5 min perfusion with 
5 μM δ-HXTX-Mg1a. 
 
FIGURE 5. Typical effects of δ-HXTX-Mg1a on insect NaV channels. Superimposed current traces 
showing typical effects of (A) 15 nM and (C) 1 μM δ-HXTX-Mg1a on DmNaV1/TipE channel currents, 
expressed in Xenopus oocytes, and (E) 30 nM δ-HXTX-Mg1a on cockroach DUM neuron INa. Currents 
were elicited by 50 ms test pulses from –90 mV to –10 mV every 5 s (A and C) and 10 s (E). In panel E 
the amplitude of peak and late INa increased steadily during initial perfusion with toxin (70 s) before 
subsequently decreasing to a plateau (5 mins). B, D and F, Effects of δ-HXTX-Mg1a on normalized gNa/V 
relationships (squares) and h∞/V (circles) in expressed DmNaV1/TipE channels (B and D) and cockroach 
DUM neurons (F). Data shows effects in the presence (open symbols), and absence (closed symbols), of 
(B) 15 nM (n = 7), (D) 1 μM (n = 3) and (E) 30 nM δ-HXTX-Mg1a (n = 3–4). The gNa/V curves were fitted 
using Eq. 1 in the Materials and methods while h∞/V curves were fitted according to Eq. 4. G, Decrease in 
cockroach DUM neuron INa amplitude in the presence of 30 nM δ-HXTX-Mg1a following 2 minutes in the 
absence of stimulation. Currents were subsequently elicited every 10 s. H, Concentration-response 
relationship of the amplitude of INa remaining at 30 ms (DmNaV1/TipE, closed squares, n = 5) or 50 ms 
(DUM neurons, grey circles, n = 3–10) as a fraction of peak control INa amplitude. Data were fitted with a 
Logistic function.  
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FIGURE 6. Typical effects of δ-HXTX-Mg1a on DUM neuron NaV channel gating. A, Effects of 30 nM 
δ-HXTX-Mg1a on NaV channel repriming kinetics in cockroach DUM neurons. NaV channel repriming 
rate was determined by normalizing peak INa elicited during a 50-ms test pulse from –90 mV to –10 mV 
against peak INa recorded during a 50-ms conditioning pulse from –90 mV to –10 mV and plotted as a 
function of the interpulse interval. With interpulse intervals greater than 2 ms, 30 nM δ-HXTX-Mg1a 
(open circles, n = 6) slowed the rate of recovery from inactivation in comparison to controls (closed 
circles, n = 6). B, Use-dependent actions of δ-HXTX-Mg1a on NaV channels in cockroach DUM neurons. 
Effects of 30 nM δ-HXTX-Mg1a on use dependent decline in INa during 20 depolarizing test pulses from 
–90 mV to –10 mV at 30 Hz. Currents were normalized to the peak INa amplitude of the first pulse in the 
train in the absence (filled symbols, n = 6), and presence (open symbols, n = 4), of 30 nM δ-HXTX-Mg1a. 
C, Effects of δ-HXTX-Mg1a (30 nM) at different hyperpolarized holding potentials. Late current (I50ms) 
amplitude only increased at holding potentials more negative than –140 mV, resulting in a modest but 
significant increase in the normalized late current (I50ms/Ipk) (n = 3, *P < 0.05, one-way repeated measures 
ANOVA). D, Effects of depolarizing post-pulses on dissociation of 30 nM δ-HXTX-Mg1a were assessed 
using 10 ms post-pulses to +140 or +200 mV applied immediately following a test pulse to –10 mV from 
–90 mV every 2 s (n = 5). NS, not significant at P < 0.05. 
 
FIGURE 7. Effect of δ-HXTX-Mg1a on action potential duration and firing frequency in cockroach 
DUM neurons. A-B, Typical superimposed action potentials generated by a single supramaximal current 
pulse every 10 s before (black traces), and following (grey traces), a 5-min perfusion with 100 nM 
δ-HXTX-Mg1a. Traces were recorded from a resting membrane potential of –60 mV (A), and –90 mV (B), 
following manual hyperpolarization. C, Same as panel B except stimuli were delivered every minute 
rather than at 10 s intervals. D, Representative effects of a 5-min perfusion with 500 μM 
3,4-di-aminopyridine (3,4-DAP, dark grey), 100 nM δ-HXTX-Mg1a (grey), and 100 nM δ-HXTX-Mg1a in 
the presence of 500 μM 3,4-DAP (light grey), on action potential duration at a resting membrane potential 
of –60 mV recorded every 10 s. E, Same as panel D except data was recorded at –90 mV following 
manual hyperpolarization. Note the slower time scale. F-H, Alterations in spontaneous action potential 
firing frequency and duration. Typical effects on tonic action potential firing before (F), and following a 
5-min perfusion with 100 nM δ-HXTX-Mg1a recorded at a resting membrane potential of –60 mV (G), 
and a holding potential of –80 mV following manual hyperpolarization (H). 
 
FIGURE 8. Comparison of δ-HXTX-Mg1a structure with other site-3 neurotoxins. The backbone of 
toxins, which is shown in ribbon representation is superimposed on the molecular surface. Critical 
residues are space-filled and colored according to their chemical nature (aromatic, yellow; aliphatic, 
green; polar, magenta; positively charged, blue and negatively charged, orange). (A) δ-HXTX-Mg1a, (B) 
δ-HXTX-Hv1a, PDB accession code, 1VTX (14); (C) δ-HXTX-Ar1a, 1QDP (15); (D) Lqh3, 1FH3 (19); 
(E) LqhαIT, 1LQH (58); (F) Aah2, 1PTX (59). Structural figures are generated using the PYMOL program 
(Delano, W.L. The PyMOL Molecular Graphics System (2002) Delano Scientific, San Carlos, CA; 
www.pymol.org). 
 
SUPPLEMENTAL FIGURE 1S. Confirmation of the structure and activity of synthetic 
δ-HXTX-Mg1a. A, Co-elution of synthetic and native δ-HXTX-Mg1a by RP-HPLC. B, Overlapping 
circular dichroism profile of native (open squares) and synthetic (closed circles) δ-HXTX-Mg1a. C, 
Comparable displacement of 125I-LqhαIT binding to rat brain synaptosomes by unlabelled LqhαIT (closed 
triangles), native δ-HXTX-Mg1a (open triangles) and synthetic δ-HXTX-Mg1a (open squares). 
 
SUPPLEMENTAL FIGURE 2S. Amide proton temperature coefficients in δ-HXTX-Mg1a. Open 
squares refer to the values of the temperature coefficients while closed squares represent amide protons 
regarded as hydrogen-bond donors. The continuous line corresponds to the value of –4.6 ppb/K. 
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TABLES 
 
 
Table 1. Structural statistics for the 20 lowest energy structures 
Distance restraints  
  Intraresidue (│i-j│= 0) 207 
  Sequential (│i-j│= 1) 181 
  Medium-range (2 ≤│i-j│≤ 4) 60 
  Long-range (│i-j│> 4) 128 
Total 576 
Ramachandran analysis (residues 2-23, 28-32)a  
  Residues in most favoured regions (%) 70 
  Residues in additional allowed regions (%) 25.1 
  Residues in generously allowed regions (%) 4.2 
  Residues in disallowed regions (%) 0.7 
Atomic r.m.s. differences between 20 conformers (Å)  
  Backbone atoms (residues 2-23, 28-32)b 0.483 ± 0.005 
  All heavy atoms (residues 2-23, 28-32)b 1.178 ± 0.005 
Deviations from idealized covalent geometry  
Bonds (Å) 0.0041 ± 0.00002 
Angles (deg.) 0.504 ± 0.002 
Impropers (deg.) 0.365 ± 0.002 
Mean Xplor energies (kcal/mol)  
Etotal -50.30 ± 2.960 
a PROCHECK-NMR was used to calculate these values. 
b None of these structures exhibited distance violations ≥ 0.4 Å and angle violations ≥ 5.0º. r.m.s. 
differences are given as the mean ± S.E.M
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Figure 5 
Structure of a spider toxin that targets sodium channel subtypes 
24 
Figure 6 
 
Structure of a spider toxin that targets sodium channel subtypes 
25 
Figure 7 
Structure of a spider toxin that targets sodium channel subtypes 
26 
Figure 8 
 
 
